138 related articles for article (PubMed ID: 19519393)
1. Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM).
Biersack B; Schobert R
Curr Med Chem; 2009; 16(18):2324-37. PubMed ID: 19519393
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
Jordan VC
J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
[No Abstract] [Full Text] [Related]
3. Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.
Dadiboyena S
Eur J Med Chem; 2012 May; 51():17-34. PubMed ID: 22405286
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes.
Zhang X; Zuo Z; Tang J; Wang K; Wang C; Chen W; Li C; Xu W; Xiong X; Yuntai K; Huang J; Lan X; Zhou HB
Bioorg Med Chem Lett; 2013 Jul; 23(13):3793-7. PubMed ID: 23726343
[TBL] [Abstract][Full Text] [Related]
5. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
Azuma K; Inoue S
Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
7. The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer.
Jaouen G; Top S; Vessières A; Leclercq G; McGlinchey MJ
Curr Med Chem; 2004 Sep; 11(18):2505-17. PubMed ID: 15379709
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogens: structure-activity relationships and use in breast cancer treatment.
Traboulsi T; El Ezzy M; Gleason JL; Mader S
J Mol Endocrinol; 2017 Jan; 58(1):R15-R31. PubMed ID: 27729460
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
Jordan VC
J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
[No Abstract] [Full Text] [Related]
11. SERMs: evolutionary chemistry, revolutionary biology.
Miller CP
Curr Pharm Des; 2002; 8(23):2089-111. PubMed ID: 12171520
[TBL] [Abstract][Full Text] [Related]
12. Protein structure-based design, synthesis strategy and in vitro pharmacological characterization of estrogen receptor alpha and beta selective compounds.
Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Elger W; Fritzemeier KH
Ernst Schering Res Found Workshop; 2004; (46):47-62. PubMed ID: 15248504
[No Abstract] [Full Text] [Related]
13. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
Jordan VC; O'Malley BW
J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
[TBL] [Abstract][Full Text] [Related]
14. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
Guo ZR; Yi X; Xu ZB
Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of tissue-specific actions of sex steroid hormones and SERM for bone remodeling].
Kato S
Clin Calcium; 2005 May; 15(5):825-30. PubMed ID: 15876746
[TBL] [Abstract][Full Text] [Related]
17. Advances in the science of estrogen receptor modulation.
Meegan MJ; Lloyd DG
Curr Med Chem; 2003 Feb; 10(3):181-210. PubMed ID: 12570707
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
Sengupta S; Jordan VC
Adv Exp Med Biol; 2008; 630():206-19. PubMed ID: 18637493
[TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test.
Clark JA; Alves S; Gundlah C; Rocha B; Birzin ET; Cai SJ; Flick R; Hayes E; Ho K; Warrier S; Pai L; Yudkovitz J; Fleischer R; Colwell L; Li S; Wilkinson H; Schaeffer J; Wilkening R; Mattingly E; Hammond M; Rohrer SP
Neuropharmacology; 2012 Nov; 63(6):1051-63. PubMed ID: 22796107
[TBL] [Abstract][Full Text] [Related]
20. Targeting the estrogen receptor using steroid-therapeutic drug conjugates (hybrids).
Dao KL; Hanson RN
Bioconjug Chem; 2012 Nov; 23(11):2139-58. PubMed ID: 23036054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
